Search Results - Christopher M. Dobson
Chris Dobson
Sir Christopher Martin Dobson (8 October 1949 – 8 September 2019) was a British chemist, who was the John Humphrey Plummer Professor of Chemical and Structural Biology in the Department of Chemistry at the University of Cambridge, and Master of St John's College, Cambridge.
Provided by Wikipedia
- Showing 1 - 20 results of 20
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ. by David C Butler, Shubhada N Joshi, Erwin De Genst, Ankit S Baghel, Christopher M Dobson, Anne Messer
Published in PLoS ONE (2016-01-01)Get full text
Article -
10
In-cell NMR characterization of the secondary structure populations of a disordered conformation of α-synuclein within E. coli cells. by Christopher A Waudby, Carlo Camilloni, Anthony W P Fitzpatrick, Lisa D Cabrita, Christopher M Dobson, Michele Vendruscolo, John Christodoulou
Published in PLoS ONE (2013-01-01)Get full text
Article -
11
-
12
The Amyloid Fibril-Forming β-Sheet Regions of Amyloid β and α-Synuclein Preferentially Interact with the Molecular Chaperone 14-3-3ζ by Danielle M. Williams, David C. Thorn, Christopher M. Dobson, Sarah Meehan, Sophie E. Jackson, Joanna M. Woodcock, John A. Carver
Published in Molecules (2021-10-01)Get full text
Article -
13
Native-state stability determines the extent of degradation relative to secretion of protein variants from Pichia pastoris. by Graham Whyteside, Marcos J C Alcocer, Janet R Kumita, Christopher M Dobson, Maria Lazarou, Richard J Pleass, David B Archer
Published in PLoS ONE (2011-01-01)Get full text
Article -
14
Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. by Leila M Luheshi, Gian Gaetano Tartaglia, Ann-Christin Brorsson, Amol P Pawar, Ian E Watson, Fabrizio Chiti, Michele Vendruscolo, David A Lomas, Christopher M Dobson, Damian C Crowther
Published in PLoS Biology (2007-10-01)Get full text
Article -
15
Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation. by Cintia Roodveldt, Adahir Labrador-Garrido, Elena Gonzalez-Rey, Christian C Lachaud, Tim Guilliams, Rafael Fernandez-Montesinos, Alicia Benitez-Rondan, Gema Robledo, Abdelkrim Hmadcha, Mario Delgado, Christopher M Dobson, David Pozo
Published in PLoS ONE (2013-01-01)Get full text
Article -
16
An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils by Emil Dandanell Agerschou, Patrick Flagmeier, Theodora Saridaki, Céline Galvagnion, Daniel Komnig, Laetitia Heid, Vibha Prasad, Hamed Shaykhalishahi, Dieter Willbold, Christopher M Dobson, Aaron Voigt, Bjoern Falkenburger, Wolfgang Hoyer, Alexander K Buell
Published in eLife (2019-08-01)Get full text
Article -
17
The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity by Catherine K. Xu, Marta Castellana-Cruz, Serene W. Chen, Zhen Du, Georg Meisl, Aviad Levin, Benedetta Mannini, Laura S. Itzhaki, Tuomas P. J. Knowles, Christopher M. Dobson, Nunilo Cremades, Janet R. Kumita
Published in Molecules (2022-02-01)Get full text
Article -
18
Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo. by Leila M Luheshi, Wolfgang Hoyer, Teresa Pereira de Barros, Iris van Dijk Härd, Ann-Christin Brorsson, Bertil Macao, Cecilia Persson, Damian C Crowther, David A Lomas, Stefan Ståhl, Christopher M Dobson, Torleif Härd
Published in PLoS Biology (2010-03-01)Get full text
Article -
19
Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. by Kiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, Vaibhav Srivastava, Andrei Shchukarev, Ann-Christin Brorsson, Gian Gaetano Tartaglia, Thomas Vogl, Rakez Kayed, Gunnar Wingsle, Jan Olsson, Christopher M Dobson, Anders Bergh, Fredrik Elgh, Ludmilla A Morozova-Roche
Published in PLoS ONE (2009-01-01)Get full text
Article -
20
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. by Gergely Tóth, Shyra J Gardai, Wagner Zago, Carlos W Bertoncini, Nunilo Cremades, Susan L Roy, Mitali A Tambe, Jean-Christophe Rochet, Celine Galvagnion, Gaia Skibinski, Steven Finkbeiner, Michael Bova, Karin Regnstrom, San-San Chiou, Jennifer Johnston, Kari Callaway, John P Anderson, Michael F Jobling, Alexander K Buell, Ted A Yednock, Tuomas P J Knowles, Michele Vendruscolo, John Christodoulou, Christopher M Dobson, Dale Schenk, Lisa McConlogue
Published in PLoS ONE (2014-01-01)Get full text
Article
